Schedule 13G ownership disclosure
UNICYCIVE THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 90466Y103
Event date: 2024-12-19
- Filing-level shares
- 3,009,021.00
- Percent of class
- 2.76%
- NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
Shares: 3,009,021.00 · Class: 2.76%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-130846
- Form type
- SCHEDULE 13G/A
- Filer
- Nantahala Capital Partners Limited Partnership
- CIK
- CIK 1502725
- Filed
- Dec 20, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13G beneficial ownership